MODELING THE HELSINKI HEART-STUDY BY MEANS OF RISK EQUATIONS OBTAINED FROM THE PROCAM STUDY AND THE FRAMINGHAM HEART-STUDY

被引:15
作者
ASSMANN, G
SCHULTE, H
机构
[1] Institut für Klinische Chemie und Laboratorium, Zentrallaboratorium, Westfälische Wilhelms-Universität, Münster, D-4400
关键词
D O I
10.2165/00003495-199000401-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Data from the Prospective Cardiovascular Münster (PROCAM) study have been used to develop a mathematical model that accurately predicts the outcome of treatment in a primary prevention study (the Helsinki Heart Study). The PROCAM study identified 8 major risk factors for coronary heart disease: age, total plasma cholesterol level, plasma high density lipoprotein (HDL)-cholesterol level, systolic blood pressure, smoking, diabetes, angina pectoris, and a family history of myocardial infarction. A single risk factor such as total plasma cholesterol level is not sufficiently sensitive to identify individuals at high risk of coronary heart disease. The total cholesterol: HDL-cholesterol ratio is recommended for clinical use. On the basis of these data, a primary prevention strategy for coronary heart disease in West Germany has been proposed to optimise the cost-effectiveness of such treatment. Future research should focus on the identification of feasible and sensitive risk factors for coronary heart disease. Fibrinogen and apolipoproteins have already attracted interest in this regard but more definitive studies are required to confirm their role as risk factors for coronary heart disease. © 1990, Adis International Limited. All rights reserved.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 11 条
[1]  
ABBOT RD, 1987, DHEW NIH872284 PUBL
[2]  
ASSMANN G, 1989, DTSCH ARZTEBLATT, V86, pA2663
[3]  
ASSMANN G, 1989, HIGH DENSITY LIPOPRO, V2, P51
[4]  
BALLEISEN L, 1987, LANCET, V2, P461
[5]   FIBRINOGEN AND RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY [J].
KANNEL, WB ;
WOLF, PA ;
CASTELLI, WP ;
DAGOSTINO, RB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (09) :1183-1186
[6]   LIPID ALTERATIONS AND DECLINE IN THE INCIDENCE OF CORONARY HEART-DISEASE IN THE HELSINKI HEART-STUDY [J].
MANNINEN, V ;
ELO, MO ;
FRICK, MH ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (05) :641-651
[7]   HEMOSTATIC FUNCTION AND ISCHEMIC-HEART-DISEASE - PRINCIPAL RESULTS OF THE NORTHWICK-PARK-HEART-STUDY [J].
MEADE, TW ;
BROZOVIC, M ;
CHAKRABARTI, RR ;
HAINES, AP ;
IMESON, JD ;
MELLOWS, S ;
MILLER, GJ ;
NORTH, WRS ;
STIRLING, Y ;
THOMPSON, SG .
LANCET, 1986, 2 (8506) :533-537
[8]  
STONE MC, 1985, J ROY COLL GEN PRACT, V35, P565
[9]   FIBRINOGEN AS A RISK FACTOR FOR STROKE AND MYOCARDIAL-INFARCTION [J].
WILHELMSEN, L ;
SVARDSUDD, K ;
KORSANBENGTSEN, K ;
LARSSON, B ;
WELIN, L ;
TIBBLIN, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (08) :501-505
[10]  
1988, EUROPEAN HEART J, V9, P571